Skip to main content
Premium Trial:

Request an Annual Quote

Gen9, Arzeda Ink Supply Agreement for Synthetic DNA

NEW YORK (GenomeWeb) – Synthetic DNA fabricator Gen9 and chemical manufacturer Arzeda have announced a supply agreement.

Under the terms of the agreement, Gen9 will supply Arzeda with megabase quantities of synthetic DNA for use in its designer cell factories capable of industrial-scale chemical production.

Arzeda CEO Alexandrew Zanghellini said the agreement would allow the Seattle-based firm to ramp up development of new molecules such as polymers, pharmaceuticals, and other advanced products. "We are revolutionizing the way chemicals are produced and Gen9's capabilities are a perfect fit for our technology," he said.

Cambridge, Massachusetts-based Gen9 is providing the DNA under its multiplex access partnership program. Arzeda represents the latest deal Gen9 has signed. The firm recently partnered with British synthetic biology network SynbiCite to increase access to synthetic DNA.